Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells

BACKGROUND: Metabolic reprogramming contributes significantly to tumor development and is tightly linked to drug resistance. The chemotherapeutic agent etoposide (VP-16) has been used clinically in the treatment of lung cancer but possess different sensitivity and efficacy towards SCLC and NSCLC. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qi, Zhou, Chenkang, Ren, Haodong, Zhang, Zhijian, Cheng, Feng, Xiong, Zhenkai, Chen, Chuantao, Yang, Jianke, Gao, Jiguang, Zhang, Yao, Xu, Lei, Fang, Jian, Cao, Yuxiang, Wei, Huijun, Wu, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583203/
https://www.ncbi.nlm.nih.gov/pubmed/33097055
http://dx.doi.org/10.1186/s12964-020-00653-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583203/
https://www.ncbi.nlm.nih.gov/pubmed/33097055
http://dx.doi.org/10.1186/s12964-020-00653-3

Ejemplares similares